2026 Q1 Portfolio Activity
In 2026 Q1, GREAT POINT PARTNERS LLC maintained a portfolio of 50 distinct positions. The most significant new addition was IMMUNITYBIO INC, now representing 5.29% of the total fund value. They heavily accumulated shares in NEKTAR THERAPEUTICS, increasing the position by 50.2%. Conversely, GREAT POINT PARTNERS LLC completely exited their position in DISC MEDICINE INC.
Position History
hover any row below to update
Loading…
Total Positions
50
Quarter
2026 Q1
Top Holding
APGE (7.2%)
Top 10 Concentration
52.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 50
GREAT POINT PARTNERS LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APGE
APOGEE THERAPEU...
|
Healthcare | 7.23% | 9.15% |
#1
Prev: #1
|
5.9 |
—
|
no change | no change |
P
S
|
374,000 | $31,479,580 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 7.18% | 5.81% |
#2
6
Prev: #8
|
6.9 |
—
|
379,893 | 27.7% |
P
S
|
1,750,000 | $31,220,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 5.77% | 6.48% |
#3
Prev: #3
|
5.3 |
—
|
400,000 | 10.5% |
P
S
|
4,215,930 | $25,084,784 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 5.59% | 6.85% |
#4
2
Prev: #2
|
3.7 |
—
|
no change | no change |
P
S
|
1,750,000 | $24,325,000 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IBRX
PUT
IMMUNITYBIO INC
|
PUT Option | 5.29% | — |
#5
Prev: #—
|
6.1 |
—
|
3,000,800 | — |
NEW
|
3,000,800 | $23,016,136 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 5.23% | 2.89% |
#6
9
Prev: #15
|
5.1 |
—
|
105,721 | 50.2% |
P
S
|
316,453 | $22,768,793 | 2019 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLGL
SOL-GEL TECHNOL...
|
Healthcare | 5.00% | — |
#7
Prev: #—
|
5.5 |
—
|
274,363 | — |
NEW
|
274,363 | $21,735,037 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 4.33% | — |
#8
Prev: #—
|
5.2 |
—
|
856,061 | — |
NEW
|
856,061 | $18,859,024 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 3.69% | — |
#9
Prev: #—
|
5.0 |
—
|
220,000 | — |
NEW
|
220,000 | $16,053,400 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 3.18% | — |
#10
Prev: #—
|
4.8 |
—
|
2,500,000 | — |
NEW
|
2,500,000 | $13,850,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 3.12% | 3.59% |
#11
Prev: #11
|
1.7 |
—
|
-10,632 | -1.6% |
P
S
|
675,000 | $13,587,750 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 3.11% | 6.18% |
#12
6
Prev: #6
|
1.2 |
—
|
-204,375 | -27.3% |
P
S
|
545,625 | $13,553,325 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 3.11% | 4.03% |
#13
3
Prev: #10
|
3.2 |
—
|
158,189 | 19.6% |
P
S
|
964,462 | $13,550,691 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 2.40% | 2.96% |
#14
2
Prev: #12
|
1.5 |
—
|
198 | 0.0% |
P
S
|
800,198 | $10,450,586 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 2.35% | — |
#15
Prev: #—
|
4.4 |
—
|
524,066 | — |
NEW
|
524,066 | $10,245,490 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NGNE
NEUROGENE INC
|
Healthcare | 2.32% | 2.34% |
#16
1
Prev: #17
|
3.4 |
—
|
150,000 | 42.9% |
P
S
|
500,000 | $10,080,000 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 2.14% | — |
#17
Prev: #—
|
4.4 |
—
|
500,000 | — |
NEW
|
500,000 | $9,320,000 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 2.10% | 1.27% |
#18
7
Prev: #25
|
3.3 |
—
|
354,596 | 36.2% |
P
S
|
1,334,130 | $9,138,791 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 2.07% | 1.80% |
#19
3
Prev: #22
|
1.8 |
—
|
no change | no change |
P
S
|
183,330 | $8,992,337 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 2.00% | 2.94% |
#20
7
Prev: #13
|
1.8 |
—
|
no change | no change |
P
S
|
1,200,000 | $8,688,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.84% | — |
#21
Prev: #—
|
4.2 |
—
|
199,348 | — |
NEW
|
199,348 | $8,019,770 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 1.72% | 1.80% |
#22
1
Prev: #21
|
1.7 |
—
|
no change | no change |
P
S
|
325,000 | $7,471,750 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 1.70% | — |
#23
Prev: #—
|
4.2 |
—
|
300,000 | — |
NEW
|
300,000 | $7,398,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.64% | — |
#24
Prev: #—
|
4.2 |
—
|
1,350,000 | — |
NEW
|
1,350,000 | $7,141,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SCYX
SCYNEXIS INC
|
Healthcare | 1.59% | — |
#25
Prev: #—
|
4.1 |
—
|
7,554,347 | — |
NEW
|
7,554,347 | $6,926,581 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 1.37% | — |
#26
Prev: #—
|
4.0 |
—
|
3,405,757 | — |
NEW
|
3,405,757 | $5,960,075 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 1.35% | 2.23% |
#27
8
Prev: #19
|
0.5 |
—
|
-2,445,215 | -52.2% |
P
S
|
2,238,496 | $5,864,860 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 1.35% | — |
#28
Prev: #—
|
4.0 |
—
|
842,106 | — |
NEW
|
842,106 | $5,861,058 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.24% | 1.59% |
#29
6
Prev: #23
|
3.0 |
—
|
212,457 | 26.3% |
P
S
|
1,020,489 | $5,377,977 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UNCY
UNICYCIVE THERA...
|
Healthcare | 1.20% | 1.49% |
#30
6
Prev: #24
|
1.5 |
—
|
no change | no change |
P
S
|
796,558 | $5,241,352 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 1.20% | — |
#31
Prev: #—
|
4.0 |
—
|
327,307 | — |
NEW
|
327,307 | $5,233,639 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PMN
PROMIS NEUROSCI...
|
Healthcare | 1.08% | — |
#32
Prev: #—
|
3.9 |
—
|
371,402 | — |
NEW
|
371,402 | $4,716,805 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 0.98% | 2.13% |
#33
13
Prev: #20
|
0.4 |
—
|
-334,032 | -52.7% |
P
S
|
300,000 | $4,263,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 0.73% | — |
#34
Prev: #—
|
3.8 |
—
|
350,000 | — |
NEW
|
350,000 | $3,188,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.67% | 0.73% |
#35
6
Prev: #29
|
1.3 |
—
|
no change | no change |
P
S
|
951,809 | $2,903,017 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.54% | 0.75% |
#36
9
Prev: #27
|
1.2 |
—
|
no change | no change |
P
S
|
82,800 | $2,339,100 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HUMA
HUMACYTE INC
|
Healthcare | 0.52% | — |
#37
Prev: #—
|
3.7 |
—
|
3,750,000 | — |
NEW
|
3,750,000 | $2,275,125 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GALT
CALL
GALECTIN THERAP...
|
CALL Option | 0.51% | — |
#38
Prev: #—
|
3.7 |
—
|
800,000 | — |
NEW
|
800,000 | $2,232,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.43% | 0.73% |
#39
11
Prev: #28
|
1.2 |
—
|
no change | no change |
P
S
|
124,666 | $1,861,263 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.41% | — |
#40
Prev: #—
|
3.7 |
—
|
50,000 | — |
NEW
|
50,000 | $1,768,000 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVXL
CALL
ANAVEX LIFE SCI...
|
CALL Option | 0.37% | — |
#41
Prev: #—
|
3.6 |
—
|
521,300 | — |
NEW
|
521,300 | $1,600,391 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRD
OPUS GENETICS I...
|
Healthcare | 0.34% | — |
#42
Prev: #—
|
3.6 |
—
|
324,340 | — |
NEW
|
324,340 | $1,475,747 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SANA
SANA BIOTECHNOL...
|
Healthcare | 0.00% | 0.92% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-700,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 2.24% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-300,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UPB
UPSTREAM BIO IN...
|
Healthcare | 0.00% | 2.64% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-300,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.00% | 2.93% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-800,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.00% | 4.68% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-350,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 6.00% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-400,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 6.38% |
Sold All 😨
(Was: #5) |
0.0 |
—
|
-581,187 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.00% | 6.44% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-250,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 50 holdings